Invst, LLC Amgen Inc Transaction History

Invst, LLC

$927 Million
Q2 2024

A detailed history of Invst, LLC transactions in Amgen Inc stock. As of the latest transaction made, Invst, LLC holds 3,232 shares of AMGN stock, worth $1.03 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

3,232

Holding current value

$1.03 Million

% of portfolio

0.11%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 16, 2024	BUY	$262.75 - $319.31 $849,208 - $1.03 Million	3,232 New	3,232 $1.01 Million
Q4 2023 Feb 07, 2024	BUY	$255.7 - $288.46 $178,734 - $201,633	699 New	699 $201,000
Q3 2022 Nov 23, 2022	SELL	$224.46 - $253.15 $1,571 - $1,772	-7 Reduced 0.8%	872 $202,000
Q2 2022 Aug 11, 2022	SELL	$230.71 - $256.74 $6,229 - $6,931	-27 Reduced 2.98%	879 $222,000
Q1 2022 May 12, 2022	SELL	$219.27 - $242.57 $1,754 - $1,940	-8 Reduced 0.88%	906 $217,000
Q4 2021 Feb 25, 2022	SELL	$198.88 - $227.6 $47,731 - $54,624	-240 Reduced 20.8%	914 $202,000
Q3 2021 Nov 10, 2021	SELL	$212.27 - $248.7 $13,373 - $15,668	-63 Reduced 5.18%	1,154 $245,000
Q2 2021 Jul 19, 2021	SELL	$233.58 - $259.14 $11,211 - $12,438	-48 Reduced 3.79%	1,217 $302,000
Q1 2021 Jun 23, 2021	SELL	$221.91 - $258.6 $157,112 - $183,088	-708 Reduced 35.88%	1,265 $303,000
Q4 2020 Jun 23, 2021	BUY	$216.38 - $257.67 $86,335 - $102,810	399 Added 25.35%	1,973 $454,000
Q3 2020 Jun 23, 2021	BUY	$234.65 - $260.95 $37,074 - $41,230	158 Added 11.16%	1,574 $402,000
Q2 2020 Jun 23, 2021	SELL	$197.81 - $242.74 $21,165 - $25,973	-107 Reduced 7.03%	1,416 $361,000
Q1 2020 Jun 23, 2021	BUY	$182.24 - $241.7 $277,551 - $368,109	1,523 New	1,523 $301,000

Others Institutions Holding AMGN

# of Institutions

3,080

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.28M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $171B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invst, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Invst, LLC with notifications on news.

Account